DYADIC INTERNATIONAL INC Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DYADIC INTERNATIONAL INC stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $200.00K, a 28.90% decline year-over-year.
- DYADIC INTERNATIONAL INC stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $400.00K.
- DYADIC INTERNATIONAL INC stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $281.31K.
- DYADIC INTERNATIONAL INC stock issued during period, value, conversion of convertible securities for fiscal 2024 was $910.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $910.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $400.00K 10-Q · filed 2025-11-12 | |
| 2023-09-30 | $281.31K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |